Press Releases

Implantica AG (publ) invites investors to a presentation of the fourth quarter 2023 at 15:00 CET on February 16. The interim report for the fourth quarter will be published at 8:00 a.m. CET on the same day.

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports that seven new scientific data presentations and abstracts on RefluxStop™ have been accepted at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Scientific Meeting in Cleveland, Ohio, April 17-20, 2024.

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure is now available at the Akershus University Hospital in Norway.

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure was included in a live surgical demonstration at the 34[th] Congress of Digestive System Surgery in Rome, Italy, where nearly 90’000 were international viewers.

RefluxStop™ – Beginning of a New Era of Acid Reflux Treatment

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the first RefluxStop™ procedures have been successfully performed by the NHS at Imperial College Healthcare NHS Trust.

Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, presented an abstract on cost-effectiveness analysis in Sweden, which was recognized among the Top 5% Posters category for its high scientific quality at the ISPOR Europe conference 2023 (International Society for Pharmacoeconomics and Outcomes Research) in Copenhagen, Denmark.

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces participation[ ]in the 3[rd] Annual EFS (European Foregut Society) Congress in Milan, Italy in early November.